FDA Inspection 1108245 — Celltrion Inc.

Celltrion Inc. — FEI 3005241015

The FDA completed an inspection of Celltrion Inc. on Oct 22, 2019 in Yeonsu. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 22, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Yeonsu (Korea (the Republic of))

Citations

IDCFRDescription
143321 CFR 211.42(c)(10)(iii)Air Supply

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.